Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04879329 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 372 participants |
| Active Locations | 122 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | January 7, 2026 (Jan 7, 2026) |
As of March 2, 2026: Clinical trial NCT04879329 is currently recruiting participants. This clinical trial study for bladder cancer is actively seeking new participants at 122 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04879329 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 122 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04879329 was last updated Jan 7, 2026 (January 7, 2026). HelloStudys verifies this status automatically.